The present invention relates a transdermal pharmaceutical composition of COX-2 inhibitors having anti-inflammatory activity. More particularly, the invention relates to a suitable transdermal pharmaceutical dosage form comprising a composition of COX-2 inhibitors or a pharmaceutically acceptable salt thereof and ph...